We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finalizes Enforcement Procedure for ClinicalTrials.gov Reporting Requirements
FDA Finalizes Enforcement Procedure for ClinicalTrials.gov Reporting Requirements
The FDA has finally put muscle behind its authority to fine flouters of the ClinicalTrials.gov reporting requirements, issuing a final guidance last week that confirms penalties of up to $10,000 per violation.